References
von Laue NC, Schwappach DL, Koeck CM (2003) The epidemiology of preventable adverse drug events: a review of the literature. Wien Klin Wochenschr 115(12):407–415
Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U et al (2000) Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 49(2):158–167
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329(7456):15–19
Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmaco l56(2):181–186
Beijer HJ, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46–54
Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A et al (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 11(1):65–72
van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA (2004) Drug-related problem classification systems. Ann Pharmacother 38(5):859–867
ASHP Statement on Pharmaceutical care. Am J Hosp Pharm (1993) 50:1720–173
Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Troger M, Azaz-Livshits T et al (2004) Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 255(6):653–663
Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A (2006) Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 15(1):23–31
Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H et al (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62(12):1075–1081
Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A et al (2005) Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 330(7486):293
Ulfvarson J, Mejyr S, Bergman U (2006) Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf 16(5):532–537
Griffiths R, Johnson M, Piper M, Langdon R (2004) A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract 10(4):166–176
Blue L, Lang E, McMurray JJ, Davie AP, McDonagh TA, Murdoch DR et al (2001) Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 323(7315):715–718
Bruggink-Andre de la Porte PW, Lok DJ, van Veldhuisen DJ, van Wijngaarden J, Cornel JH, Zuithoff NP et al (2006) Added value of a physician-and-nurse-directed heart failure clinic. Results from the DEAL-HF study. Heart. 25
Backstrom M, Ekman E, Mjorndal T (2007) Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol 63(6):613–618
Backstrom M, Mjorndal T, Dahlqvist R (2002) Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf 11(8):647–650
Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C (2003) Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Saf 12(7):589–593
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41
Läkemedelsindustriföreningen LIF (2003) Interactions. http://drugdb. Janusinfo.se/ddb/interactions/
Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM et al (2006) Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 61(5):511–515
Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al (2003) Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1(2):82–89
Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4(1):36–41
Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R (2005) Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 11 165(7):790–795
Routledge PA, O’Mahony MS, Woodhouse KW (2004) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57(2):121–126
Leppik IE (2006) Epilepsy in the elderly. Epilepsia 47(Suppl 1):65–70
van Roon EN, Flikweert S, le Comte M, Langendijk PN, Kwee-Zuiderwijk WJ, Smits P et al (2005) Clinical relevance of drug-drug interactions : a structured assessment procedure. Drug Saf 28(12):1131–1139
Buurma H, De Smet PA, Egberts AC (2006) Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. Drug Saf 29(8):723–732
Glassman PA, Belperio P, Simon B, Lanto A, Lee M (2006) Exposure to automated drug alerts over time: effects on clinicians’ knowledge and perceptions. Med Care 44(3):250–256
Acknowledgements
The authors wish to thank Stockholm Söder Hospital and the Drug & Therapeutics Committee, Stockholm South, Stockholm County Council, for financial support, and the participating nurses and physicians for making this project possible.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergqvist, M., Ulfvarson, J., Andersen Karlsson, E. et al. A nurse-led intervention for identification of drug-related problems. Eur J Clin Pharmacol 64, 451–456 (2008). https://doi.org/10.1007/s00228-007-0449-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0449-3